FDA approves world's first CRISPR gene-editing drug for sickle cell disease

Historic FDA approval of the first CRISPR-Cas9 drug for Sickle Cell Disease based on discoveries from Jennifer Doudna & Emmanuelle Charpentier, CRISPR Therapeutics & Vertex Pharmaceuticals.

FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease

NASA Helps Study One of the World’s Most Diverse Ecosystems